Retatrutide RT10 10mg*10vials
Retatrutide is a triple-receptor agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors, representing one of the most advanced metabolic research peptides available today.
This 10mg single-vial specification is ideal for researchers conducting dose-response studies, long-term metabolic mechanism experiments, and preclinical research projects. The triple-pathway activation works synergistically across multiple metabolic systems.
GLP-1 and GIP dual activation supports insulin sensitivity, glycemic regulation, and appetite modulation through gut hormone pathways. The glucagon receptor component enhances resting energy expenditure and supports lipid metabolism research.
This product is supplied as a lyophilized powder in sterile glass vials, suitable for reconstitution with bacteriostatic water. Each batch undergoes purity testing and comes with a certificate of analysis.
10 vials per pack, designed for research laboratory use.